SOBRsafe Inc. (NASDAQ: SOBR), a company specializing in next-generation alcohol monitoring technology, has entered into definitive agreements for a private placement expected to generate approximately $2.0 million in gross proceeds. The company will issue 1,290,324 shares of common stock, or pre-funded warrants in lieu thereof, along with Series C and Series D warrants to purchase additional shares, at a combined purchase price of $1.55 per unit. H.C. Wainwright & Co. is acting as the exclusive placement agent for this transaction.
The funding is significant because it provides capital for SOBRsafe to advance its unique transdermal alcohol detection technology. Unlike traditional methods that require breath, blood, or urine samples, SOBRsafe's system detects alcohol presence through a user's skin in real-time. This passive, dignified approach has applications across multiple sectors including behavioral health, family law, and consumer markets. The company's backend data platform enables continuous monitoring solutions that could transform how alcohol screening is conducted in sensitive environments.
According to the announcement, net proceeds from the offering are intended for working capital and general corporate purposes. The warrants issued in the private placement carry an exercise price of $1.30 per share and are exercisable immediately. Series C warrants expire five years after the effective date of the applicable resale registration statement, while Series D warrants expire after twenty-four months. This financial structure provides both immediate capital and potential future funding options for the company.
The importance of this funding extends beyond the immediate financial injection. As workplace safety concerns grow and behavioral health monitoring becomes more sophisticated, SOBRsafe's technology addresses a critical need for non-invasive alcohol detection. The company positions itself as enabling "trust and empowerment" through its human-centered approach to monitoring. For industries requiring alcohol-free environments—from transportation to healthcare to manufacturing—this technology offers a more dignified alternative to traditional testing methods.
Investors and industry observers can find additional information about SOBRsafe through the company's online resources. The full press release detailing the private placement is available at https://ibn.fm/RC1sW, while ongoing company updates are maintained in their newsroom at https://ibn.fm/SOBR. The company's main website at https://www.sobrsafe.com provides comprehensive information about their technology and applications.
This funding round represents a vote of confidence in SOBRsafe's approach to alcohol monitoring at a time when workplace safety and behavioral health monitoring are receiving increased attention. The company's ability to secure this private placement through a reputable firm like H.C. Wainwright suggests growing interest in alternative alcohol detection technologies that prioritize user dignity while maintaining accuracy and reliability. As regulatory environments evolve and workplace safety standards become more stringent, technologies like SOBRsafe's could see expanded adoption across multiple industries.
